Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.001 par value
- Total 13F shares
- 23,788,793
- Total 13F value
- $48,053,747
- Share change
- +884,823
- Put/Call ratio
- 33%
- SEC-reported price per share
- $2.02
- Number of holders
- 57
- Value change
- +$1,931,780
- Number of buys
- 31
- Number of sells
- 18
- Shares outstanding
- 120,192,308
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q4 2023
Institutions
57
Top holders
10
AQST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Ownership snapshot
Top reported holders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Largest current holder
Bratton Capital Managemen...
13D/G signal
—
Evidence rows
15
Latest as of
30 Sep 2023
13F
Lead comparable stake: 8.2%
Showing 1-6 of 15 holder rows.
Quick read
Bratton Capital Management, L.P. leads the comparable SEC ownership view at 8.2%.
Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Bratton Capital Management, L.P.
8.2%
ARMISTICE CAPITAL, LLC
4%
VANGUARD GROUP INC
1.4%
RENAISSANCE TECHNOLOGIES LLC
0.94%
Vahanian & Associates Financial P...
0.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
Company
|
8.2%
|
$1,501,766
9,810,958 shares
|
— | 30 Sep 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
4%
|
$7,344,000
4,800,000 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1.4%
|
$2,598,937
1,698,652 shares
|
— | 30 Sep 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.94%
|
$1,728,000
1,129,189 shares
|
— | 30 Sep 2023 |
| Vahanian & Associates Financial Planning Inc. |
13F
Company
|
0.6%
|
$1,104,825
722,108 shares
|
— | 30 Sep 2023 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
0.46%
|
$841,000
550,484 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
57
Shares
23,788,793
Rows available
57
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
45
Q4 2023 holders
57
Holder diff
12
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend